Moderna, Inc.Equity-NMS: MRNA
Equity-NMS: MRNA
$166.61
+2.61
(25 May)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$166.61
Open
$166.61
Today’s high
$170.47
Today’s low
$162.00
52W low
$62.55
52W high
$170.47
1Y
31.74%
5Y
50.08%
PE
-10.53
EPS (TTM)
-15.86
Shares O/S
383.24M
Market cap
63.85B
Insights
MRNA has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
MRNA price is above its 200 day moving average
MRNA PE is in the top end of its range over the past 2 years
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Moderna, Inc.

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases.

Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others. .


FAQs

Can I buy Moderna, Inc. shares in India?
How to buy Moderna, Inc. shares in India?
What is the share price of Moderna, Inc.?
What is the Market Capitalization of Moderna, Inc.?
What is the PE ratio of Moderna, Inc.?
Is Moderna, Inc. a good stock to buy?
In which sector / industry does Moderna, Inc. operate?